World

PM Modi terrific, ‘will not be forgotten’: US President Donald Trump

PTI Washington | Updated on April 09, 2020 Published on April 09, 2020

Prime Minister Narendra Modi and US President Donald Trump. File photo   -  Kamal Narang

India on Monday agreed to lift the ban on export of Hydroxychloroquine to the US

Amid the medical fraternity racing against time for a panacea for Covid-19, which has infected a whopping 4.3 lakh Americans and claimed over 14,600 lives, United States (US) President Donald Trump on Wednesday thanked Prime Minister Narendra Modi for allowing export of Hydroxychloroquine, deemed a possible cure against the disease.

I want to thank Prime Minister Modi of India for allowing us to have what we requested for the problem arose and he was terrific. We will remember it, Trump told reporters at his daily White House news conference on coronavirus.

In a tweet, hours earlier, Trump praised Modi for his strong leadership and said that India’s help during this crisis will not be forgotten.

Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten! he said.

Thank you, Prime Minister, Narendra Modi for your strong leadership in helping not just India, but humanity, in this fight! Trump said in a tweet that son went viral. It was retweeted more than 60,000 times and liked by over two lakhs Twitterati.

By Wednesday night, more than 14,600 Americans had lost their lives due to coronavirus and over 4.3 lakhs have tested positive for the dreaded disease. Scientists and the medical fraternity are racing against time to find a vaccine and a therapeutic solution to it.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the Covid-19 and it is being tested on more than 1,500 coronavirus patients in New York. Anticipating that it will work, given initial positive results, Trump has bought more than 30 million doses of Hydroxychloroquine for potential treatment of Covid-19 patients.

Trump, in a phone call last week, had requested Prime Minister Modi to release the hold on American order of the malaria drug, of which India is the major producer. India lifted the hold on Tuesday.

India on Monday agreed to lift the ban on export of Hydroxychloroquine to the US. Three Gujarat-based companies would export these tablets to the US, Chief Minister Vijay Rupani said on Tuesday. India manufactures 70 per cent of the world’s supply of Hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.

The country has a production capacity of 40 tonnes of Hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each. Since the drug is also used to auto-immune diseases like rheumatoid arthritis and lupus, manufacturers have good production capacities that can also be ramped up.

Indian Americans have welcomed the decision.

President Trump is a Graceful and Grateful Man. He is honest when he says that he will not forget India’s gesture. He is a True Friend of India, said Al Mason, a Trump supporter.

Thank you President Trump. ! I think you are well orchestrating the compulsion of history and demand of destiny that we and India be the best of friends, joined at the hip and yet as family, free hearts and minds to love across a spectrum of emotions, but always together, tweeted Indian American attorney Ravi Batra.

Published on April 09, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.